Evidence map›Paper›PMID 33896869›Full record

ArticleInternal medicine (Tokyo, Japan)2021

Fatal Thrombotic Microangiopathy and Posterior Reversible Encephalopathy Syndrome in a Patient with Anti-melanoma Differentiation-associated Gene 5 Antibody-positive Dermatomyositis.

Shotaro Yamamoto, Takao Nagashima, Yoichiro Akiyama, Katsuya Nagatani, Masahiro Iwamoto, Seiji Minota

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Shotaro YamamotoDivision of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan.
Takao NagashimaDivision of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan.
Yoichiro AkiyamaDivision of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan.
Katsuya NagataniDivision of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan.
Masahiro IwamotoDivision of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan.
Seiji MinotaDivision of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan.
Jichi Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 56-year-old woman presented with dermatomyositis positive for anti-melanoma differentiation-associated gene 5 antibody. No interstitial lung disease was detected. Despite treatment with methylprednisolone pulse therapy and cyclosporine, dysphagia developed. Furthermore, the presence of thrombocytopenia, elevated lactate dehydrogenase levels, and an undetectable haptoglobin level suggested the possibility of thrombotic microangiopathy (TMA). Disturbed consciousness developed shortly after TMA onset, and brain magnetic resonance imaging revealed hyperintensity lesions in the bilateral basal ganglia, thalami, and brainstem. The patient was diagnosed with atypical posterior leukoencephalopathy syndrome before dying of heart failure later that day. In conclusion, early TMA recognition and prompt intensive treatment are critical in such cases.

Indexed as

DermatomyositisPosterior Leukoencephalopathy SyndromeThrombotic MicroangiopathiesBrainFemaleHumansMagnetic Resonance ImagingMiddle Agedhemophagocytic lymphohistiocytosishemophagocytic syndromeinterstitial lung diseasethrombotic thrombocytopenic purpura

Identifiers

PMID33896869
PMCPMC8580758
OpenAlexW3157111069

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.